source:[1] 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says - Fierce Biotech (https://www.fiercebiotech.com/biotech/2026-ou ...)[2] Private finance structures to drive bumper Japan M&A into 2026, Goldman says - Reuters (https://www.reuters.com/world/asia-pacific/pr ...)[3] PitchBook Releases 2026 Outlook Reports Showcasing Key Trends Shaping Global Private Markets - Markets Financial Content (https://markets.financialcontent.com/wral/art ...)